PepVault: Peptide Tracker landing page review
Higher than 4 of the 63 other launches on the public record (6%)
“The page lists features but hides the cost and the specific user it serves, risking immediate bounce.”
What we read, 20 Nov at 20:03, at laptop and phone width.
Fix this first
List the specific cost of the primary subscription or feature in the ‘About this app’ section
Fatal · minutes · up to +2.3. From your page’s line “In-app purchases” (copy test O1).
Then
- 2Add a line naming the target user, e.g., ‘Designed for [specific user type] managing multiple peptide vials’+5.6
- 3Move the ‘scattered notes or spreadsheets’ pain to the first paragraph of the ‘About this app’ section+5.6
The numbers
This page, in numbers.
Its four scores against the public record, and its public grills over time.
Its four axes
The page shows a free Install button but never says what the in-app purchases cost or why to start now.
- ✕missed:O1Findable
- ✕missed:O2Legible
- ✕missed:O3Matched
- ✕missed:O4Reason to act
- ◐half:O5Risk
O1, missed: In-app purchases.
Choose an axis to read it.
Where 36 sits
4 of 63other launches score lower
The public record, 22 Nov: each launch counted once, by its latest public grill.
What a stranger sees first.
Before scrolling, on a laptop and on a phone.


- The button “Install”3.7%4.0%
- Headline5.2%11.8%
- Menu bar6.6%17.6%
The button “Install” gets 4.0% of the first looks on 3.7% of the screen.
After five seconds a stranger would say: “Some app for tracking peptides, made by a company I don't know.” They should be able to say: “An Android log for your peptide doses, vials, injection sites and reminders.”
Predicted, not measured: a model trained on 1,721 screens people looked at for 3 seconds with eye trackers. On 27 pages it had not seen it ranked the spots people looked at above other spots 83% of the time; “people look at the middle” scores 59%. It can over-weight loud things. UEyes (Jiang et al., CHI 2023, CC BY 4.0) · TranSalNet · 20 Nov
Your message, as a buyer reads it.
Four questions, in the order a buyer asks them. Each fix quotes your page and ends in something you can do today.
1. Do I get what it is?
Clarity 493 of 5 tests pass.“simple and powerful”
generic adjectives provide no factual information about the product's actual utility.
Proposalyou decideReplace adjectives with a concrete fact, e.g., ‘Log a dose in [number] taps’.
2. Is it for me?
Audience 252 of 4 tests pass.“no named audience in copy”
a visitor is unsure if the tool is for medical patients, biohackers, or athletes and bounces.
Proposalyou decideAdd a line naming the target user, e.g., ‘Designed for [specific user type] managing multiple peptide vials’.“No more scattered notes or spreadsheets”
the primary pain point is buried at the bottom, failing to hook the user immediately.
Proposalyou decideMove the ‘scattered notes or spreadsheets’ pain to the first paragraph of the ‘About this app’ section.
What people type
Google Trends · BingYours“peptide tracker”, the phrase in its headline, is the most searched of the five.
“peptide tracker” on Google, week by week
Shaded, the last 3 months: −56% on Google · Bing: too few searches to check
- “peptide tracker”36too few to count✓ headline
- “peptide dose log”under 1too few to countno
- “peptide injection tracker”under 1too few to countno
- “track peptide vials”under 1too few to countno
- “peptide reminder app”under 1too few to countno
Google Trends: the five phrases in one search, worldwide, the past 12 months, so they share one scale (100 = the busiest week of any of them; shares, not counts). Bing Webmaster Tools: the exact phrase, worldwide, an average week. Read 20 Nov.
Against this page
Its headline
peptidemate: Peptide Tracker
The headline uses “peptide tracker”.
3. Do I want it?
Offer 10 of 5 tests pass.“In-app purchases”
a visitor does not know if the app is free or expensive and leaves without installing.
Proposalyou decideList the specific cost of the primary subscription or feature in the ‘About this app’ section.“no reason to act now”
there is no incentive to install today versus bookmarking for later.
Proposalyou decideAdd a limited-time launch price or a ‘free for the first [number] users’ offer.
4. Do I believe it?
Proof 77Nothing to fix here.- Keep: The screenshots clearly show the actual product interface.
- Keep: The use of industry terms like 'reconstituted' and 'vial strength' speaks the user's language.
Why you, not them.
Products a buyer may meet while looking for what you sell, read the same day, and the free option most of them pick.
| Starts at | Proof from outside | Says what it is | |
|---|---|---|---|
| Peptide Tracker Log & Reminder | Free · In-App Purchases (“100% free. No subscription. No paywall.”) | “4.9 out of 5”, “3.1K Ratings”, “used by over 100,000 people” | yes |
| Regimen | “Free to download. Free for your first compound.” Premium price not shown | “Loved by 25,000+ people”, “4.8 ★” App Store rating | yes |
Found by searching your category, read on their own pages the day of this grill. Others a buyer may meet: PepTrack: Peptide Tracker, Dosed, PeptideJournal, PepBuddy.
The option most buyers pick: A spreadsheet or notes on the phone.
It costs nothing, the user already has it, and it can hold doses, dates and vials without installing anything.
What sets you apart, in your page’s words
“Keep your schedules, dose records, vial information, notes, reminders, and history together in one simple app.”
Where each one hesitates.
Our critic reads your page as three different strangers would. A simulation from the page alone: not real people, not your analytics.
The person tracking their own routine
Uses several peptide vials and wants one place for doses and reminders.
Hesitates at the top of the listingO1
“In-app purchases”
Which part is free and what will it cost me once I have logged a month of doses?
Would stay if: A plain line saying what is free and what the paid part costs (O1).
The switcher
Has tried two other peptide trackers and a spreadsheet before.
Hesitates at the first line of About this appC3
“simple and powerful”
Every tracker says this; what does this one do that the last one did not?
Would stay if: A concrete fact instead of the adjectives, such as how few taps a dose takes (C3).
The newcomer
Just started a first peptide and has never used a tracker.
Hesitates at the title and first paragraphA1
“track your peptide routine, doses, vials, schedules, reminders, and progress”
Is this for someone like me with one vial, or for people running complicated stacks?
Would stay if: A line naming who it is built for (A1) and the spreadsheet pain moved to the first paragraph (A3).
The pattern: All three have to guess something the page never says: the cost (O1), who it is for (A1), or why it beats what they use now (C3, A3).
What passed, and 5 to tidy.
We click your main button, “Install”, as a visitor would, then read the page as AI and search do, and measure speed, links, accessibility, privacy and the technical basics. Beside the score, never in it.
Ready for Show HN and Product Hunt?
What those crowds check first, and drafts written from your page's own words. Edit them before you post; we never post for you.
| Can I try it without an account? | Install is free, but the page does not say whether an account is needed. | fix first |
| Who made it? | Only the studio “Dual Teams” and a name in the developer contact block. | fix first |
| Does the page say what it is? | Yes, the title says “Peptide Tracker”. | ready |
| Is the price shown? | No, it only says “In-app purchases” with no amounts. | fix first |
Drafts for Show HN, Product Hunt and X“Show HN: peptidemate – Log peptide doses, vials, injection sites and reminders”Show the draftsHide
Your score in detail.
How 36 adds upevery axis and its weight, the level, every test, every grill of this pageShow the sumHide
Level 1 of 4 Raw
- ✓First grill
- Cooked — reach 60
- Well done — no round left on this launch
- ✓Before and after — finish round 2
Clarity35% of the score31149
Audience18% of the score2225
Offer29% of the score141
Every grill of this page
- 1 of 227Raw8 Oct 2026
- 2 of 236Raw20 Nov 2026+9You are here
Your launch, read the same way.
Free. No card.
Ready to launch? The Launch Kit: your agent submits you to up to 85 free directories · $49 →